Figure 5From: Assessment of health-related quality of life in patients receiving stem cell therapy for end-stage liver disease: an Egyptian studyFollow-up data from our previous study. Changes in serum albumin (A), serum bilirubin (B), prothrombin concentration (C), aspartate transaminase values (D), alanine transaminase values (E), in both control and treated groups. Pre, pretreatment; 1st, first month; 2nd, second month; 3rd, third month; 6th, sixth month after treatment.Back to article page